Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Grebely

Showing results (121-130 of 368) with videos related to

Pageof 37
Sort By:
Addiction (Abingdon, England)|June 7, 2017
New developments and opportunities for preventing hepatitis C virus (HCV) among people who use and inject drugs-announcing an Addiction seriesMatthew Hickman, Jason Grebely, Julie Bruneau, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 30, 2013
Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residentsMaryam Alavi, Jesse D Raffa, Gregory D Deans, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|June 11, 2016
Deep sequencing increases hepatitis C virus phylogenetic cluster detection compared to Sanger sequencingVincent Montoya, Andrea Olmstead, Patrick Tang, et al.
Drug and Alcohol Dependence|February 23, 2020
Socio-demographic and ecological factors associated with anti-HCV prevalence in people who inject drugs: A systematic reviewSamantha Colledge, Janni Leung, Jason Grebely, et al.
Hepatology Communications|February 7, 2018
Survival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000-2014)Reem Waziry, Jason Grebely, Janaki Amin, et al.
The International Journal on Drug Policy|March 12, 2023
"You'll come in and dose even in a global pandemic": A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemicAnna Conway, Carla Treloar, Sione Crawford, et al.
Journal of the International AIDS Society|May 2, 2024
Impact of simplified HCV diagnostic strategies on the HCV epidemic among men who have sex with men in the era of HIV oral pre-exposure prophylaxis in Taiwan: a modelling studyHuei-Jiuan Wu, Sophy TingFang Shih, Tanya L Applegate, et al.
The Lancet Regional Health. Western Pacific|July 8, 2024
The cost-effectiveness of integrating simplified HCV testing into HIV pre-exposure prophylaxis (PrEP) and treatment services among men who have sex with men in TaiwanHuei-Jiuan Wu, Tanya L Applegate, Jisoo A Kwon, et al.
Plos One|June 30, 2016
Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective CohortJoseph S Doyle, Jason Grebely, Tim Spelman, et al.
BMC Public Health|October 1, 2017
Estimating the number of people who inject drugs in AustraliaSarah Larney, Matthew Hickman, Rebecca Guy, et al.
Pageof 37

Showing results (121-130 of 368) with videos related to

Sort By:
Pageof 37
Addiction (Abingdon, England)|June 7, 2017
New developments and opportunities for preventing hepatitis C virus (HCV) among people who use and inject drugs-announcing an Addiction seriesMatthew Hickman, Jason Grebely, Julie Bruneau, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 30, 2013
Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residentsMaryam Alavi, Jesse D Raffa, Gregory D Deans, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|June 11, 2016
Deep sequencing increases hepatitis C virus phylogenetic cluster detection compared to Sanger sequencingVincent Montoya, Andrea Olmstead, Patrick Tang, et al.
Drug and Alcohol Dependence|February 23, 2020
Socio-demographic and ecological factors associated with anti-HCV prevalence in people who inject drugs: A systematic reviewSamantha Colledge, Janni Leung, Jason Grebely, et al.
Hepatology Communications|February 7, 2018
Survival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000-2014)Reem Waziry, Jason Grebely, Janaki Amin, et al.
The International Journal on Drug Policy|March 12, 2023
"You'll come in and dose even in a global pandemic": A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemicAnna Conway, Carla Treloar, Sione Crawford, et al.
Journal of the International AIDS Society|May 2, 2024
Impact of simplified HCV diagnostic strategies on the HCV epidemic among men who have sex with men in the era of HIV oral pre-exposure prophylaxis in Taiwan: a modelling studyHuei-Jiuan Wu, Sophy TingFang Shih, Tanya L Applegate, et al.
The Lancet Regional Health. Western Pacific|July 8, 2024
The cost-effectiveness of integrating simplified HCV testing into HIV pre-exposure prophylaxis (PrEP) and treatment services among men who have sex with men in TaiwanHuei-Jiuan Wu, Tanya L Applegate, Jisoo A Kwon, et al.
Plos One|June 30, 2016
Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective CohortJoseph S Doyle, Jason Grebely, Tim Spelman, et al.
BMC Public Health|October 1, 2017
Estimating the number of people who inject drugs in AustraliaSarah Larney, Matthew Hickman, Rebecca Guy, et al.
Pageof 37